US FDA Grants Investigational Device Exemption (IDE) to EndoQuest™ Robotics for Its Flexible Robotic System Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and Drug Administration (FDA) has granted EndoQuest Robotics, Inc., a privately-held pioneer in the development of flexible endoluminal...

EndoQuest™ Robotics Submits Investigational Device Exemption (IDE) Application for Its Flexible Robotic System Houston, TX, Nov. 14, 2024 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a privately held medical device company and pioneer in the development of flexible endoluminal robotic technologies, has...